Chemical exchange saturation transfer for predicting response to stereotactic radiosurgery in human brain metastasis
暂无分享,去创建一个
Hany Soliman | Arjun Sahgal | Hatef Mehrabian | Sofia Chavez | G. Stanisz | A. Sahgal | H. Soliman | R. Rola | S. Chavez | Greg J. Stanisz | Hatef Mehrabian | K. Desmond | Radoslaw Rola | Kimberly L. Desmond
[1] Jing Yuan,et al. APT‐weighted and NOE‐weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses , 2013, Magnetic resonance in medicine.
[2] M. Symms,et al. A simple correction for B1 field errors in magnetization transfer ratio measurements. , 2006, Magnetic resonance imaging.
[3] D. Kondziolka,et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline , 2009, Journal of Neuro-Oncology.
[4] Jinyuan Zhou,et al. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts , 2008, NMR in biomedicine.
[5] P Vaupel,et al. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. , 2001, Seminars in oncology.
[6] Michael Brady,et al. MIND: Modality independent neighbourhood descriptor for multi-modal deformable registration , 2012, Medical Image Anal..
[7] S. Brockstedt,et al. Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy , 2006, Acta radiologica.
[8] Daniel Paech,et al. Correction of B1‐inhomogeneities for relaxation‐compensated CEST imaging at 7 T , 2015, NMR in biomedicine.
[9] Daniel Paech,et al. Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology , 2015, PloS one.
[10] E. Oermann,et al. The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications. , 2014, Neurosurgery.
[11] A. Elhan,et al. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. , 2007, Diagnostic and interventional radiology.
[12] S. Vermeulen,et al. The management of brain necrosis as a result of SRS treatment for intra-cranial tumors , 2014 .
[13] J. Gore,et al. Studies of magnetization transfer and relaxation in irradiated polymer gels - interpretation of MRI-based dosimetry , 2001, Physics in medicine and biology.
[14] Hye-Young Heo,et al. Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi‐solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla , 2016, Magnetic resonance in medicine.
[15] Jinyuan Zhou,et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.
[16] Kimberly L Desmond,et al. Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T , 2014, Magnetic resonance in medicine.
[17] J. Knisely,et al. A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain Metastases , 2011, American Journal of Neuroradiology.
[18] Martin Bendszus,et al. Response assessment criteria for brain metastases: proposal from the RANO group. , 2015, The Lancet. Oncology.
[19] A Gregory Sorensen,et al. Imaging pH using the chemical exchange saturation transfer (CEST) MRI: Correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH , 2008, Magnetic resonance in medicine.
[20] Jinyuan Zhou,et al. Three‐dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement , 2013, Journal of magnetic resonance imaging : JMRI.
[21] Daniel L. Polders,et al. Amide proton transfer (APT) imaging of brain tumors at 7 T: The role of tissue water T1‐Relaxation properties , 2017, Magnetic resonance in medicine.
[22] Jinyuan Zhou,et al. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast , 2010, NeuroImage.
[23] Makoto Ochi,et al. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy , 2001, European Radiology.
[24] Edward Pan,et al. In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma , 2014, Proceedings of the National Academy of Sciences.
[25] Tao Jin,et al. MR imaging of the amide‐proton transfer effect and the pH‐insensitive nuclear overhauser effect at 9.4 T , 2013, Magnetic resonance in medicine.
[26] Jinyuan Zhou,et al. Amide proton transfer MR imaging of prostate cancer: A preliminary study , 2011, Journal of magnetic resonance imaging : JMRI.
[27] Liane Oehme,et al. A method for model-free partial volume correction in oncological PET , 2012, EJNMMI Research.
[28] D. Kondziolka,et al. MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. , 1999, Radiology.
[29] D. Rigamonti,et al. Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice , 2014, Neurosurgical Review.
[30] Ravinder Reddy,et al. CEST signal at 2 ppm (CEST@2ppm) from Z‐spectral fitting correlates with creatine distribution in brain tumor , 2014, NMR in biomedicine.
[31] Erik Tryggestad,et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides , 2010, Nature Medicine.
[32] R M Henkelman,et al. Quantitative interpretation of magnetization transfer , 1993, Magnetic resonance in medicine.
[33] Richard A. E. Edden,et al. Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T , 2013, NeuroImage.
[34] C. Stippich,et al. Primary motor cortex activation and lateralization in patients with tumors of the central region☆ , 2013, NeuroImage: Clinical.
[35] Jinyuan Zhou,et al. Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.
[36] P. Desmond,et al. Diffusion Tensor Imaging in Glioblastoma Multiforme and Brain Metastases: The Role of p, q, L, and Fractional Anisotropy , 2008, American Journal of Neuroradiology.
[37] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[38] Koji Yamashita,et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. , 2014, Neuro-oncology.
[39] J. Borén,et al. Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation , 2012, Cell Death and Differentiation.
[40] A. Okumura,et al. The characterization of human brain tumor using magnetization transfer technique in magnetic resonance imaging. , 1999, Neurological research.
[41] R. Boellaard,et al. Reproducibility of quantitative (R)-[11C]verapamil studies , 2012, EJNMMI Research.
[42] Stephen M. Smith,et al. A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..
[43] J G Pipe,et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. , 1995, AJNR. American journal of neuroradiology.
[44] T. Hirai,et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.
[45] Greg J. Stanisz,et al. Diffusion MR in Biological Systems: Tissue Compartments and Exchange , 2010 .
[46] Ravinder Reddy,et al. Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI , 2012, NMR in biomedicine.
[47] H. Critchley,et al. Quantitative Magnetization Transfer Imaging as a Biomarker for Effects of Systemic Inflammation on the Brain , 2015, Biological Psychiatry.
[48] Kimberly L Desmond,et al. Understanding quantitative pulsed CEST in the presence of MT , 2012, Magnetic resonance in medicine.
[49] Thomas E Yankeelov,et al. Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.
[50] Christophe Ley,et al. Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median , 2013 .
[51] Jinyuan Zhou,et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.
[52] Brian D Ross,et al. Predicting and monitoring cancer treatment response with diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.
[53] Thomas E Yankeelov,et al. Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response , 2013, Magnetic resonance in medicine.
[54] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[55] B. Bobek-Billewicz,et al. Fibre integrity and diffusivity of the pyramidal tract and motor cortex within and adjacent to brain tumour in patients with or without neurological deficits. , 2011, Folia neuropathologica.
[56] T L Chenevert,et al. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[57] R S Balaban,et al. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST) , 2000, Magnetic resonance in medicine.
[58] M. Pui,et al. Magnetization transfer analysis of brain tumor, infection, and infarction , 2000, Journal of magnetic resonance imaging : JMRI.